Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.

Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang S, Sun X, Li J, Deng Y, Jiang Y, Ding Y.

Gut. 2010 Sep;59(9):1226-35. doi: 10.1136/gut.2009.202739. Epub 2010 Jul 26.

PMID:
20660701
2.

LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.

Wang H, Li W, Jin X, Cui S, Zhao L.

Eur J Cancer. 2013 Mar;49(4):974-83. doi: 10.1016/j.ejca.2012.09.032. Epub 2012 Oct 18.

PMID:
23084841
3.

LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.

Yang F, Zhou X, Du S, Zhao Y, Ren W, Deng Q, Wang F, Yuan J.

PLoS One. 2014 Jun 23;9(6):e100557. doi: 10.1371/journal.pone.0100557. eCollection 2014.

4.

Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.

Grunewald TG, Kammerer U, Kapp M, Eck M, Dietl J, Butt E, Honig A.

BMC Cancer. 2007 Oct 23;7:198.

5.

Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells.

Grunewald TG, Kammerer U, Schulze E, Schindler D, Honig A, Zimmer M, Butt E.

Exp Cell Res. 2006 Apr 15;312(7):974-82. Epub 2006 Jan 23. Erratum in: Exp Cell Res. 2006 Aug 1;312(13):2631.

PMID:
16430883
6.

miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.

Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L.

Eur J Cancer. 2013 Dec;49(18):3924-35. doi: 10.1016/j.ejca.2013.07.149. Epub 2013 Aug 19.

PMID:
23968734
7.

LASP-1 promotes tumor proliferation and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

Zheng J, Yu S, Qiao Y, Zhang H, Liang S, Wang H, Liu Y, Zhou F, Jiang J, Lu S.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1891-9. doi: 10.1007/s00432-014-1759-3. Epub 2014 Jul 3.

PMID:
24990592
8.

Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer.

Tang S, Yang G, Meng Y, Du R, Li X, Fan R, Zhao L, Bi Q, Jin J, Gao L, Zhang L, Li H, Fan M, Wang Y, Wu K, Liu J, Fan D.

Cancer Biol Ther. 2010 Jan;9(2):88-95. Epub 2010 Jan 9.

PMID:
19901563
9.

Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.

Zheng P, Liu YX, Chen L, Liu XH, Xiao ZQ, Zhao L, Li GQ, Zhou J, Ding YQ, Li JM.

J Proteome Res. 2010 Oct 1;9(10):4897-905. doi: 10.1021/pr100712t.

PMID:
20806969
10.

Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.

Zhu XL, Liang L, Ding YQ.

Int J Colorectal Dis. 2008 Nov;23(11):1041-7. doi: 10.1007/s00384-008-0520-2. Epub 2008 Jul 30.

PMID:
18665374
11.

[Impact of LASP-1 expression on proliferation and tumorigenesis of human colorectal cancer cell line SW480].

Zhao L, Ding YQ.

Zhonghua Bing Li Xue Za Zhi. 2010 Dec;39(12):830-4. Chinese.

PMID:
21215099
12.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
13.

A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.

Hao JM, Chen JZ, Sui HM, Si-Ma XQ, Li GQ, Liu C, Li JL, Ding YQ, Li JM.

J Pathol. 2010 Mar;220(4):475-89. doi: 10.1002/path.2668.

PMID:
20077526
14.

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.

Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH.

Carcinogenesis. 2013 Apr;34(4):803-11. doi: 10.1093/carcin/bgs400. Epub 2012 Dec 28.

15.

Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.

Zhao L, Liu L, Wang S, Zhang YF, Yu L, Ding YQ.

J Cancer Res Clin Oncol. 2007 Oct;133(10):771-82. Epub 2007 May 15.

PMID:
17503081
16.

LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.

Li Z, Chen Y, Wang X, Zhang H, Zhang Y, Gao Y, Weng M, Wang L, Liang H, Li M, Zhang F, Zhao S, Liu S, Cao Y, Shu Y, Bao R, Zhou J, Liu X, Yan Y, Zhen L, Dong Q, Liu Y.

Cancer Lett. 2016 Mar 28;372(2):239-50. doi: 10.1016/j.canlet.2016.01.008. Epub 2016 Jan 18. Erratum in: Cancer Lett. 2016 Jun 28;376(1):197-198.

PMID:
26797416
17.

Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.

Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A, Butt E.

Br J Cancer. 2007 Jan 29;96(2):296-305. Epub 2007 Jan 9.

18.

mTOR signaling pathway is a target for the treatment of colorectal cancer.

Zhang YJ, Dai Q, Sun DF, Xiong H, Tian XQ, Gao FH, Xu MH, Chen GQ, Han ZG, Fang JY.

Ann Surg Oncol. 2009 Sep;16(9):2617-28. doi: 10.1245/s10434-009-0555-9. Epub 2009 Jun 11.

PMID:
19517193
20.

Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer.

Lin BR, Chang CC, Che TF, Chen ST, Chen RJ, Yang CY, Jeng YM, Liang JT, Lee PH, Chang KJ, Chau YP, Kuo ML.

Gastroenterology. 2005 Jan;128(1):9-23.

PMID:
15633118

Supplemental Content

Support Center